Keynote: Compliance By Design – How US Pharma Need to Embrace the Role of AI

As regulations in healthcare grow more complex, U.S. pharmaceutical companies are turning to artificial intelligence to stay ahead. "Compliance By Design" highlights how integrating AI into daily processes can help pharma companies prevent compliance issues before they happen, streamline audits, and reduce errors. Embracing AI not only makes staying compliant easier but also boosts innovation, helping companies navigate regulations more effectively and confidently